As molecular events in PHF8-mediated anti-tumor immunity, type 1 interferons and interferon-stimulated genes (ISGs) were significantly upregulated after Phf8 loss in CT26 and MC38 cells, whereas Phf8 reintroduction could block this effect (Fig. 2d). The gene discussed is DDX53; the disease is neoplasm.